![Ian Clements](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Clements
Corporate Officer/Principal at
National Investor Relations Institute
Profile
Ian Clements is a professional with experience in various firms.
He is currently a member of The Royal Society of Chemistry and the National Investor Relations Institute.
He has previously worked as Director-Marketing Communications at BIOVIA, Inc., Senior Director-Corporate Communications at Sequenom, Inc., Head-Investor Relations & Corporate Communications at Avanir Pharmaceuticals, Inc., VP-Investor Relations & Corporate Communications at Tobira Therapeutics, Inc., and Vice President-Investor Relations at Dermira, Inc. Currently, he is serving as the Chief Financial Officer at Mirum Pharmaceuticals, Inc. Dr. Clements holds a doctorate from The University of Manchester, an undergraduate degree from Staffordshire University, and an MBA from The Open University.
Ian Clements active positions
| Companies | Position | Start |
|---|---|---|
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
Former positions of Ian Clements
| Companies | Position | End |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2023-05-14 |
| DERMIRA, INC. | Investor Relations Contact | 2019-02-28 |
| TOBIRA THERAPEUTICS INC | Investor Relations Contact | 2016-11-30 |
| AVANIR PHARMACEUTICALS INC | Investor Relations Contact | 2015-05-31 |
| ACCELRYS, INC. | Sales & Marketing | - |
Training of Ian Clements
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
BIOVIA, Inc.
 BIOVIA, Inc. Packaged SoftwareTechnology Services Develops cloud-based and enterprise R&D, modeling and informatics platform | Technology Services |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
Staffordshire University
 Staffordshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
- Stock Market
- Insiders
- Ian Clements
